IL154850A0 - Polysubstituted imidazopyridine derivatives and pharmaceutical compositions containing the same - Google Patents

Polysubstituted imidazopyridine derivatives and pharmaceutical compositions containing the same

Info

Publication number
IL154850A0
IL154850A0 IL15485001A IL15485001A IL154850A0 IL 154850 A0 IL154850 A0 IL 154850A0 IL 15485001 A IL15485001 A IL 15485001A IL 15485001 A IL15485001 A IL 15485001A IL 154850 A0 IL154850 A0 IL 154850A0
Authority
IL
Israel
Prior art keywords
polysubstituted
same
pharmaceutical compositions
compositions containing
imidazopyridine derivatives
Prior art date
Application number
IL15485001A
Other languages
English (en)
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of IL154850A0 publication Critical patent/IL154850A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL15485001A 2000-10-25 2001-10-23 Polysubstituted imidazopyridine derivatives and pharmaceutical compositions containing the same IL154850A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00123133 2000-10-25
PCT/EP2001/012207 WO2002034749A1 (en) 2000-10-25 2001-10-23 Polysubstituted imidazopyridines as gastric secretion inhibitors

Publications (1)

Publication Number Publication Date
IL154850A0 true IL154850A0 (en) 2003-10-31

Family

ID=8170193

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15485001A IL154850A0 (en) 2000-10-25 2001-10-23 Polysubstituted imidazopyridine derivatives and pharmaceutical compositions containing the same

Country Status (19)

Country Link
US (2) US6869949B2 (xx)
EP (1) EP1332143A1 (xx)
JP (1) JP2004512338A (xx)
KR (1) KR20040011423A (xx)
CN (1) CN1692113A (xx)
AU (2) AU1056302A (xx)
BR (1) BR0114873A (xx)
CA (1) CA2426616A1 (xx)
EA (1) EA008151B1 (xx)
HR (1) HRP20030323A2 (xx)
HU (1) HUP0302308A2 (xx)
IL (1) IL154850A0 (xx)
MX (1) MXPA03003706A (xx)
NO (1) NO325736B1 (xx)
NZ (1) NZ525281A (xx)
PL (1) PL360412A1 (xx)
SK (1) SK5072003A3 (xx)
WO (1) WO2002034749A1 (xx)
ZA (1) ZA200302038B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004512338A (ja) * 2000-10-25 2004-04-22 アルタナ ファルマ アクチエンゲゼルシャフト 胃液分泌抑制剤としてのポリ置換イミダゾピリジン
DE10145457A1 (de) * 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
RS72004A (xx) 2002-02-15 2006-10-27 Altana Pharma Ag. Triciklična n-acil jedinjenja
TWI295575B (en) * 2002-04-24 2008-04-11 Altana Pharma Ag Nitrosated imidazopyridines
WO2004056362A2 (en) * 2002-12-20 2004-07-08 Altana Pharma Ag 8-trialkysyloxy-2-methyl-9-phenyl-7-0 xo-7,8,9,10- tetrahydroimidazo ‘1,2-h! ‘1,7! naphthyridines
PL377581A1 (pl) * 2003-02-17 2006-02-06 Altana Pharma Ag Połączenia zawierające imidazopirydyny oraz ich zastosowanie do leczenia chorób zapalnych przewodu pokarmowego
CA2520288A1 (en) * 2003-04-03 2004-10-14 Altana Pharma Ag Process for the production of imidazopyridin-8-ones
AR044129A1 (es) 2003-05-06 2005-08-24 Altana Pharma Ag Compuestos intermedios de imidazopiridina. proceso de preparacion.
EP1682133A1 (en) 2003-11-03 2006-07-26 AstraZeneca AB Imidazo 1,2-a pyridine derivatives for the treatment of silent gastro-esophageal reflux
AR046893A1 (es) * 2003-12-16 2005-12-28 Altana Pharma Ag Bencimidazoles triciclicos
AU2004298453A1 (en) 2003-12-19 2005-06-30 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
AR046941A1 (es) * 2003-12-19 2006-01-04 Altana Pharma Ag Imidazopiridinas triciclicas y su uso como inhibidores de secrecion de acido gastrico
CA2582256A1 (en) * 2004-10-01 2006-04-13 Altana Pharma Ag Substituted tricyclic benzimidazoles
AR051375A1 (es) * 2004-10-15 2007-01-10 Altana Pharma Ag Imidazopiridinas difluoro substituidas
WO2008058990A1 (en) * 2006-11-16 2008-05-22 Nycomed Gmbh 7,7-disubstituted pyrano-[2,3-c]-imidazo-[1,2-a]-pyridine derivatives and their use as gastric acid secretion inhibitors
WO2012027240A1 (en) * 2010-08-23 2012-03-01 Schering Corporation Fused tricyclic inhibitors of mammalian target of rapamycin

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
JPH06502659A (ja) * 1991-05-31 1994-03-24 ファイザー インク 免疫抑制剤としてのラパマイシンプロドラッグの使用
DE4308095A1 (de) * 1993-03-13 1994-09-15 Hoechst Ag Prodrug-Derivate von Arzneimittelwirkstoffen mit Hydroxylgruppen, Verfahren zu deren Herstellung und ihre Verwendung
SE9401197D0 (sv) * 1994-04-11 1994-04-11 Astra Ab Active compounds
ZA982445B (en) * 1997-03-24 1998-09-24 Byk Gulden Lomberg Chem Fab Tetrahydropyrido compounds
BR9807883A (pt) * 1997-03-24 2000-02-22 Byk Gulden Lomberg Chem Fab Compostos de tetraidropirido
CN101255164A (zh) * 1997-05-28 2008-09-03 奥坦纳医药公司 稠合的二氢吡喃类化合物及其用途
HUP0001555A3 (en) * 1997-10-30 2001-01-29 Altana Pharma Ag Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
US6436953B1 (en) * 1998-09-23 2002-08-20 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyridoethers
JP2002528548A (ja) * 1998-11-03 2002-09-03 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング イミダゾナフチリジン
DE60002855T2 (de) * 1999-04-17 2004-05-06 Altana Pharma Ag Haloalkoxy-imidazonaphthyridine
CZ20023210A3 (cs) * 2000-03-29 2003-01-15 Altana Pharma Ag Pyrano(2,3-)imidazo(-1,2-a)pyridinová sloučenina
ATE332302T1 (de) * 2000-03-29 2006-07-15 Altana Pharma Ag Alkylierte imidazopyridinderivate
ES2283408T3 (es) * 2000-03-29 2007-11-01 Nycomed Gmbh Imidazopiridinas triciclicas.
EP1313740B1 (en) * 2000-03-29 2005-11-30 ALTANA Pharma AG Prodrugs of imidazopyridine derivatives
JP2004512338A (ja) * 2000-10-25 2004-04-22 アルタナ ファルマ アクチエンゲゼルシャフト 胃液分泌抑制剤としてのポリ置換イミダゾピリジン

Also Published As

Publication number Publication date
EA008151B1 (ru) 2007-04-27
AU2002210563B2 (en) 2007-03-01
KR20040011423A (ko) 2004-02-05
US6869949B2 (en) 2005-03-22
NZ525281A (en) 2004-11-26
NO20031830D0 (no) 2003-04-24
AU1056302A (en) 2002-05-06
HUP0302308A2 (hu) 2003-11-28
HRP20030323A2 (hr) 2005-04-30
CN1692113A (zh) 2005-11-02
NO20031830L (no) 2003-04-24
WO2002034749A1 (en) 2002-05-02
CA2426616A1 (en) 2002-05-02
BR0114873A (pt) 2003-07-01
EP1332143A1 (en) 2003-08-06
US20040106642A1 (en) 2004-06-03
US7141567B2 (en) 2006-11-28
PL360412A1 (en) 2004-09-06
NO325736B1 (no) 2008-07-14
US20040214852A1 (en) 2004-10-28
MXPA03003706A (es) 2005-01-25
ZA200302038B (en) 2004-04-22
JP2004512338A (ja) 2004-04-22
EA200300478A1 (ru) 2003-12-25
SK5072003A3 (en) 2003-09-11

Similar Documents

Publication Publication Date Title
IL150734A0 (en) Azaindole derivatives and pharmaceutical compositions containing the same
IL156354A0 (en) Pyridoindole derivatives and pharmaceutical compositions containing the same
IL152451A0 (en) 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same
HUP0301178A3 (en) Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same
IL153123A0 (en) N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same
IL151952A0 (en) Aminopyridine derivatives and pharmaceutical compositions containing the same
IL152889A0 (en) Imidazopyridine and imidazopyrimidine derivatives and pharmaceutical compositions containing the same
IL152490A0 (en) Pyridine derivatives and pharmaceutical compositions containing the same
HUP0400784A3 (en) Bicyclic heterocondensated pyrrolcarboxamide derivatives, their use and pharmaceutical compositions containing them
HUP0400837A3 (en) 2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them
HUP0204474A3 (en) 1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use
IL161616A0 (en) Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same
IL154786A0 (en) Pyrazole derivatives and pharmaceutical compositions containing the same
IL156368A0 (en) Pyrazole derivatives and pharmaceutical compositions containing the same
IL145757A0 (en) Pyrazole derivatives and pharmaceutical compositions containing the same
IL145756A0 (en) Pyrazole derivatives and pharmaceutical compositions containing the same
IL158044A0 (en) Cyclopropylindole derivatives and pharmaceutical compositions containing the same
IL158300A0 (en) Bisarylimidazol derivatives and pharmaceutical compositions containing the same
IL156812A0 (en) Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same
IL150449A0 (en) Aniline derivatives and pharmaceutical compositions containing the same
IL152094A0 (en) Ecteinascidin derivatives and pharmaceutical compositions containing the same
IL157740A0 (en) Heterocyclic derivatives and pharmaceutical compositions containing the same
IL147214A0 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
IL154850A0 (en) Polysubstituted imidazopyridine derivatives and pharmaceutical compositions containing the same
IL150905A0 (en) Andrographolide derivatives and pharmaceutical compositions containing the same